Graves’ ophthalmopathy is an eye problem that happens when the body’s immune system attacks the tissues around the eyes, usually in people who also have Graves’ disease (autoimmune thyroid overactivity). The tissues and muscles behind the eyes become swollen and thick, which can push the eyes forward, make the eyelids pull back, and sometimes affect vision. Doctors often call it thyroid eye disease (TED).PubMed+2EyeWiki+2
Graves’ ophthalmopathy (also called thyroid eye disease) is an autoimmune problem where your immune system attacks the tissues around the eyes, especially fat and muscles in the eye socket. This makes the eyes look pushed forward, feel gritty or dry, and sometimes causes double vision or even vision loss. Good care usually needs a team: an eye specialist, an endocrinologist, and sometimes surgeons and rheumatologists, following evidence-based guidelines such as the 2021 EUGOGO recommendations and more recent reviews on thyroid eye disease.PubMed+2Wiley Online Library+2
Other names for Graves’ ophthalmopathy
Doctors and researchers use several names for the same condition. These names all describe eye disease linked to thyroid problems:
-
Thyroid eye disease (TED).EyeWiki+1
-
Graves’ orbitopathy.PubMed+1
-
Graves’ orbital disease.MDPI+1
-
Thyroid-associated ophthalmopathy (TAO).etj.bioscientifica.com+1
-
Thyroid ophthalmopathy.The Lancet+1
-
Endocrine exophthalmos (older term for bulging eyes from hormone disease).American Thyroid Association+1
All these names point to the same basic idea: eye changes caused by an autoimmune thyroid disorder.PubMed+1
Types of Graves’ ophthalmopathy
Doctors describe Graves’ ophthalmopathy in a few different “types” or categories. These help decide follow-up and treatment.PubMed+1
-
Active (inflammatory) Graves’ ophthalmopathy
In the active type, the eye tissues are inflamed and “angry.” The eyes may suddenly become red, swollen, painful, and more bulging over weeks or months. This phase usually lasts 6–24 months and is the time when treatment can change the course of the disease most effectively.PubMed+1 -
Inactive (stable or fibrotic) Graves’ ophthalmopathy
In the inactive type, the inflammation has settled down. The swelling is less, but scarring and stiffness of the eye muscles and eyelids may remain. Symptoms such as double vision or lid retraction can stay, but they change slowly. Surgery is usually considered in this phase, if needed.PubMed+1 -
Mild Graves’ ophthalmopathy
Mild disease causes irritation, dryness, tearing, mild redness, or slight eyelid retraction without serious damage to vision. It bothers day-to-day life a little but does not threaten sight. Many people with mild disease can be managed with eye drops, lifestyle changes, and close follow-up.PubMed+2Cleveland Clinic+2 -
Moderate-to-severe Graves’ ophthalmopathy
This type causes more obvious bulging of the eyes, lid retraction, and double vision. People may have trouble closing their eyes fully or looking in certain directions. It affects work, driving, or reading. More active medical treatment and sometimes surgery are usually needed.PubMed+2etj.bioscientifica.com+2 -
Sight-threatening Graves’ ophthalmopathy
This is the most serious type. Pressure on the optic nerve or severe exposure of the front of the eye can lead to fast vision loss. People may notice blurred vision, faded colors, or a dark area in their visual field. This is an emergency and needs urgent specialist care.PubMed+2PMC+2 -
Unilateral vs bilateral Graves’ ophthalmopathy
In most people, both eyes are affected (bilateral), but sometimes one eye looks much worse, or only one eye is clearly involved at first (unilateral). Even with one eye showing stronger signs, the disease process is usually present on both sides.EyeWiki+1
Causes and risk factors of Graves’ ophthalmopathy
Graves’ ophthalmopathy is autoimmune. That means the body’s defense system attacks its own tissues by mistake. Several causes and risk factors work together.PubMed+2MDPI+2
-
Graves’ disease (autoimmune hyperthyroidism)
The main cause is Graves’ disease, where antibodies stimulate the thyroid gland to make too much thyroid hormone. The same antibodies also react with cells behind the eyes, which leads to swelling of muscles and fat in the eye socket.PubMed+1 -
Autoimmune attack on TSH receptor in orbital tissues
Special antibodies against the TSH receptor and related targets are found in the blood of many patients. These antibodies activate fibroblasts and fat cells in the orbit, which then produce swelling, inflammation, and extra tissue.PubMed+2MDPI+2 -
Genetic susceptibility
Some people inherit genes that make them more likely to develop Graves’ disease and eye disease, such as certain HLA types. Having a family history of autoimmune thyroid disease raises the chance of Graves’ ophthalmopathy.MDPI+1 -
Cigarette smoking
Smoking is the strongest known modifiable risk factor. Smokers are more likely to develop Graves’ ophthalmopathy, and the disease is often more severe and responds less well to treatment.PubMed+2ScienceDirect+2 -
Radioiodine (RAI) therapy for Graves’ hyperthyroidism
Radioiodine used to treat the overactive thyroid can trigger new or worse eye disease in some people, especially smokers and those with very high antibody levels or poor thyroid control after treatment.PMC+2PubMed+2 -
Poor control of thyroid hormone levels (hyper or hypo)
Both ongoing hyperthyroidism and long-lasting hypothyroidism after treatment are linked to a higher risk and worse course of thyroid eye disease. Stable, normal thyroid function lowers risk.PubMed+1 -
High TSH receptor antibody levels (TRAb / TSI)
Higher blood levels of TSH receptor antibodies are associated with a greater chance of eye disease, more activity, and a higher risk of worsening, especially after radioiodine.PubMed+2KoreaMed Synapse+2 -
Female sex and hormonal influences
Graves’ disease and Graves’ ophthalmopathy are more common in women, likely because of hormonal and immune differences. But when men are affected, their disease is often more severe.The Lancet+1 -
Older age
Older adults are more likely to develop moderate-to-severe or sight-threatening forms, and they may have other illnesses that increase risk. Age changes in tissues and blood vessels may worsen damage from inflammation.The Lancet+1 -
High cholesterol and other lipid problems
High total cholesterol and LDL have been linked to a higher risk of thyroid eye disease. Abnormal fats in the blood may add to inflammation and damage of small vessels in the orbit.PubMed+1 -
Diabetes and metabolic problems
Diabetes and metabolic syndrome are associated with more severe disease in some studies. High blood sugar can damage small vessels and nerves and may worsen inflammation and tissue healing.The Lancet+1 -
Stressful life events
Serious physical or emotional stress may trigger or worsen autoimmune activity in some people who already carry risk genes. Stress hormones can change immune balance and thyroid function, which may set off Graves’ disease and eye disease.MDPI+1 -
Thyroid surgery
Thyroid removal is sometimes done for Graves’ disease. In most cases it reduces eye risk, but in a few patients the sudden change in thyroid status can briefly influence the course of eye disease, especially if hormone levels are not well replaced.American Thyroid Association+1 -
External radiation to head and neck
Radiotherapy to the head and neck for cancers can injure normal tissues and disturb immune responses. In people with autoimmune thyroid disease, this may increase inflammation or mimic some changes seen in thyroid eye disease.American Thyroid Association+1 -
Other autoimmune diseases
Conditions like type 1 diabetes, vitiligo, rheumatoid arthritis, or pernicious anemia often occur together with autoimmune thyroid disease. A general tendency toward autoimmunity can make Graves’ ophthalmopathy more likely.MDPI+1 -
Obesity and metabolic syndrome
Extra body fat releases inflammatory chemicals (cytokines). These signals may add to the immune attack in the orbit and also link to the cholesterol and blood sugar changes seen in people with more severe disease.ScienceDirect+1 -
Environmental pollutants and irritants
Some studies suggest that air pollution, certain chemicals, or irritants may influence autoimmune thyroid disease, though the link is not fully clear. These factors may act together with genes and smoking.MDPI+1 -
Infections as immune triggers
Infections may “wake up” the immune system and cause cross-reaction with thyroid or orbital tissues in people who are genetically at risk. This is still being studied, but it is one possible trigger.MDPI+1 -
Uncontrolled hypothyroidism after radioiodine
If the thyroid becomes underactive after radioiodine and hormone replacement is delayed or not adjusted well, eye disease can worsen, especially in people with high antibody levels.PubMed+1 -
Long duration of untreated Graves’ hyperthyroidism
People who live for a long time with overactive thyroid hormone levels without proper treatment are more likely to develop eye problems, because the immune attack and tissue changes have more time to build up.The Lancet+1
Symptoms and signs of Graves’ ophthalmopathy
Symptoms are what the person feels; signs are what the doctor sees. Many people have both at the same time.EyeWiki+2Cleveland Clinic+2
-
Bulging eyes (proptosis)
The eyes can look as if they are pushed forward from the sockets. This happens because the muscles and fat behind the eyes swell. It may be more obvious in photos or when looking from the side.EyeWiki+2Cleveland Clinic+2 -
Eyelid retraction (upper lid pulled high)
The upper eyelid sits higher than normal, so more of the white of the eye is visible above the iris. This is very common and is sometimes called Dalrymple’s sign. It gives a “staring” look.EyeWiki+2NCBI+2 -
Lid lag on looking down
When the person looks down, the upper lid does not move smoothly with the eye, so the white remains visible. This lid lag is another classic sign and can make the eyes feel dry when looking down to read.EyeWiki+1 -
Red eyes and bloodshot appearance
The white of the eye and the inner eyelids can look red and irritated. The tiny blood vessels are more visible because of inflammation, dryness, or exposure of the surface of the eye.EyeWiki+2tedimpact.com+2 -
Swollen eyelids and puffy tissues around the eyes
The eyelids and tissues around the eyes may look puffy, especially in the morning. This soft-tissue swelling is due to inflammation and fluid build-up in the eyelids and orbit.EyeWiki+2tedimpact.com+2 -
Dry eyes and gritty or sandy feeling
Many people describe a feeling like sand or dust in the eyes. Because the lids do not close fully or are pulled back, the tear film becomes unstable and the surface of the eye dries out.Cleveland Clinic+2Cleveland Clinic Journal of Medicine+2 -
Watery eyes and tearing
Surprisingly, dry eyes often water more, because the eye reflexively produces tears in response to irritation. Lid retraction and bulging eyes also change how tears spread and drain, leading to constant tearing.Cleveland Clinic+2tedimpact.com+2 -
Light sensitivity (photophobia)
People may feel discomfort or pain in bright light. The exposed surface of the eye is more sensitive, and any inflammation of the cornea or conjunctiva can make light feel harsh.Cleveland Clinic+2Cleveland Clinic Journal of Medicine+2 -
Eye pain or pressure behind the eyes
Some people feel a dull ache, pressure, or headache behind or around the eyes. This comes from swelling inside the tight bony orbit and from inflamed tissues being stretched.PMC+2Glaucoma Today+2 -
Double vision (diplopia)
When the eye muscles become thick and stiff, the eyes may not point in the same direction. This misalignment causes double vision, especially when looking up, down, or to the side. It can be constant or only in some gaze positions.PMC+2ScienceDirect+2 -
Difficulty moving the eyes
People may notice it is hard to look up, down, or sideways. The eyes can feel “stuck.” The doctor may see restricted eye movements because the muscles are enlarged and fibrotic.EyeWiki+2MDPI+2 -
Blurred vision
Vision can be blurry because the surface of the eye is dry or damaged, or in more serious cases, because swelling compresses the optic nerve at the back of the eye. Blurring that is sudden or progressive needs urgent review.PMC+2Cleveland Clinic+2 -
Faded color vision or dark patches in the visual field
In sight-threatening disease, the optic nerve may be compressed. People may notice colors look washed out, or there may be dark areas or missing parts in their visual field. This is a medical emergency.PMC+2ScienceDirect+2 -
Trouble closing the eyes fully (lagophthalmos)
Bulging eyes and lid retraction can make it hard to close the eyelids completely during sleep or blinking. This exposes the cornea and can lead to pain, ulcers, and infection if not protected.NCBI+1 -
Cosmetic and emotional distress
Changes in appearance, such as staring eyes or facial asymmetry, can cause anxiety, low self-esteem, and social avoidance. Emotional impact is a real part of the disease and should be addressed as part of care.Cleveland Clinic Journal of Medicine+2MDPI+2
Diagnostic tests for Graves’ ophthalmopathy
Doctors use a mix of eye exam, general physical exam, blood tests, and imaging to diagnose Graves’ ophthalmopathy and to judge its activity and severity.ResearchGate+3PubMed+3journals.viamedica.pl+3
Physical examination and basic clinical tests
-
Eye and facial inspection
The doctor looks carefully at the eyes and face for signs such as eyelid retraction, bulging eyes, redness, swelling, and difficulty closing the lids. This visual inspection is the starting point for diagnosis.EyeWiki+2NCBI+2 -
Assessment of resistance to retropulsion
The doctor gently presses on the closed eye to feel how easily it moves back into the socket. In Graves’ ophthalmopathy, the swollen tissues make the eye feel firm and resistant to pressure.EyeWiki+2Glaucoma Today+2 -
Visual acuity test (reading chart)
A standard eye chart (like Snellen) is used to measure how clearly a person can see. Any drop in visual acuity may indicate surface eye problems or, in severe cases, optic nerve involvement.PMC+2NCBI+2 -
Color vision testing
Simple color plates (for example, Ishihara charts) help check whether the optic nerve is working normally. Loss of color brightness, especially for red, can be an early sign of optic neuropathy from orbital pressure.PMC+2ScienceDirect+2 -
Pupil examination and RAPD check
The doctor shines a light into each eye to check how the pupils react. A relative afferent pupillary defect (RAPD) suggests the optic nerve is not carrying signals properly and can appear in severe Graves’ ophthalmopathy.PMC+2NCBI+2 -
Visual field testing (confrontation or automated)
Visual fields are tested by finger counting at the bedside or by machine. Loss of parts of the field (for example, central or peripheral defects) can signal compression of the optic nerve at the orbital apex.PMC+2ScienceDirect+2 -
Fundus examination (ophthalmoscopy)
Using an ophthalmoscope, the doctor looks at the optic disc and retina. Swelling or paleness of the optic disc may show damage from pressure or poor blood supply, which can occur in sight-threatening disease.PMC+2NCBI+2 -
General thyroid and systemic exam
The neck is examined for an enlarged thyroid, and the doctor checks heart rate, tremor, weight, and skin. These findings support the diagnosis of Graves’ disease, which is closely tied to the eye condition.American Thyroid Association+2PMC+2
Manual / office-based eye movement and measurement tests
-
Ocular motility assessment
The person is asked to look in all directions while the doctor watches eye movements. Restricted movement in certain directions suggests thickened, stiff eye muscles, which is typical of Graves’ ophthalmopathy.PMC+2MDPI+2 -
Cover–uncover and prism cover tests
These tests help measure misalignment of the eyes (strabismus). The doctor covers one eye and then the other, sometimes using prisms, to see how much the eyes “jump” to take up fixation. This quantifies double-vision problems.PMC+2Glaucoma Today+2 -
Hertel exophthalmometry (proptosis measurement)
A Hertel exophthalmometer is a simple device placed at the outer corners of the eye sockets to measure how far the eyes protrude. This measurement is useful for diagnosis and for tracking change over time.EyeWiki+2Frontiers+2 -
Intraocular pressure measurement (tonometry)
Eye pressure is measured with an instrument such as Goldmann applanation or a handheld tonometer. Pressure can increase, especially when looking up, because enlarged muscles push on the globe. High pressure may risk glaucoma and needs treatment.NCBI+2Glaucoma Today+2 -
Forced duction test
In some cases, the doctor gently moves the eye with forceps (usually under anesthesia) to see if movement is mechanically restricted by tight muscles or tissues. This helps distinguish muscle stiffness from nerve problems.Glaucoma Today+1
Laboratory and pathological tests
-
Thyroid function tests (TSH, free T4, free T3)
Blood tests for TSH and thyroid hormones confirm whether the thyroid is overactive, normal, or underactive. Abnormal thyroid function supports a diagnosis of Graves’ disease in someone with typical eye findings.American Thyroid Association+2NCBI+2 -
TSH receptor antibodies (TRAb / TSI)
Blood tests that measure antibodies against the TSH receptor help confirm autoimmune Graves’ disease. Higher levels are linked with more active and severe eye disease and a higher risk of worsening after radioiodine.PubMed+2KoreaMed Synapse+2 -
Other thyroid autoantibodies (anti-TPO, anti-thyroglobulin)
These antibodies show that the thyroid problem is autoimmune. They are not specific for Graves’ ophthalmopathy but often coexist and support the autoimmune nature of the disease.MDPI+2PMC+2 -
General blood tests (lipids, glucose, inflammatory markers)
Blood lipids, blood sugar, and sometimes markers like C-reactive protein can be checked. High cholesterol, diabetes, or other risk factors may influence disease severity and are important for overall health management.PubMed+2ScienceDirect+2
Electrodiagnostic test
-
Visual evoked potentials (VEP)
VEP tests measure the electrical response of the brain to visual signals. If the optic nerve is compressed, the signal may be delayed or reduced. This test helps confirm subtle optic nerve damage when the exam is unclear.PMC+2ScienceDirect+2
Imaging tests
-
Orbital computed tomography (CT) scan
CT scans show detailed pictures of the eye sockets and bones. In Graves’ ophthalmopathy, CT often shows enlarged eye muscles with tendon sparing and increased fat volume. CT is also useful for surgical planning and for detecting optic nerve compression.PMC+2MDPI+2 -
Orbital magnetic resonance imaging (MRI)
MRI gives excellent images of soft tissues in the orbit. It can show inflamed muscles, fat, and the optic nerve, and it helps assess disease activity with special sequences. MRI is now a key imaging tool for diagnosis and treatment planning.PMC+2MDPI+2 -
Orbital ultrasonography (USG)
Ultrasound can measure muscle thickness and detect some soft-tissue changes. It is less detailed than CT or MRI but is inexpensive and radiation-free, and it can be useful in follow-up or in places where advanced imaging is not available.journals.viamedica.pl+1 -
SPECT / SPECT-CT imaging (activity assessment)
Single photon emission computed tomography (SPECT), sometimes combined with CT, can show areas of increased blood flow and activity in the orbital tissues. This may help distinguish active inflammation from inactive, fibrotic disease in complex cases.journals.viamedica.pl+2ResearchGate+2
Non-pharmacological treatments
-
Smoking cessation
Stopping smoking is one of the single most powerful non-drug steps in Graves’ ophthalmopathy. Cigarette smoke makes inflammation in the eye socket worse and increases the risk of severe, sight-threatening disease and poor response to treatment. The purpose of quitting is to lower eye inflammation, slow progression, and improve treatment results. The mechanism is mainly by reducing toxic oxidants and immune-stimulating chemicals from smoke that activate orbital fibroblasts and immune cells.ScienceDirect+1 -
Avoiding second-hand smoke
Even if the patient does not smoke, being around smoke can worsen eye redness, dryness, and swelling. The aim is to protect the eyes from irritants that keep the local tissues inflamed. Second-hand smoke brings similar toxic particles into the tears and small vessels around the eyes, which can trigger or maintain autoimmune activity and oxidative stress in the orbit.ScienceDirect+1 -
Optimizing thyroid hormone levels (euthyroidism)
Keeping thyroid hormone in the normal range with appropriate treatment of Graves’ disease is crucial. The purpose is not just to control heart rate or weight, but also to keep the eye disease more stable and less active. When thyroid levels swing between overactive and underactive, immune signals to the orbit can increase, so stable euthyroidism lowers the drive for inflammation in the eye tissues.Medscape eMedicine+1 -
Lubricating eye drops (“artificial tears”)
Frequent use of preservative-free artificial tears keeps the eye surface moist and comfortable. The goal is to reduce gritty feeling, light sensitivity, and risk of corneal damage when the eyelids do not close fully. These drops work by adding a protective liquid layer over the cornea, diluting inflammatory molecules in the tear film, and reducing friction each time the eyelids blink.EyeWiki+1 -
Night-time eye ointment and moisture shields
At night, thicker gel or ointment, sometimes combined with a moisture chamber or plastic shield, protects the cornea when the eyelids do not close completely. The purpose is to prevent dry spots and small scratches that can become infections or ulcers. The mechanism is simple: the ointment forms a greasy barrier that slows evaporation, while shields trap humidity around the eyes.EyeWiki+1 -
Head elevation during sleep
Sleeping with the head slightly raised on extra pillows or an adjustable bed can reduce morning eye swelling. The aim is to let fluid drain away from the orbit overnight. When the head is flat, venous blood and tissue fluid can pool in the eye socket, so elevation uses gravity to lessen periorbital edema and pressure around the optic nerve.PMC+1 -
Cool compresses for comfort
Applying clean, cool (not icy) compresses over closed eyelids can temporarily calm redness, heat, and puffiness. The purpose is to ease discomfort and make the eyes feel less tight or full. Cooling gently narrows small blood vessels and slows inflammatory cell activity in the eyelids and conjunctiva, which can damp down local inflammation for a short time.PMC+1 -
Sunglasses and light protection
Dark, wrap-around sunglasses help with light sensitivity and shield the eyes from wind, dust, and UV light. The goal is to reduce irritation and protect the exposed cornea. Mechanistically, sunglasses block UV-induced oxidative stress and physical drying from moving air, making the eye surface more stable and less inflamed in people with protruding eyes.EyeWiki+1 -
Avoiding irritants (wind, dust, strong fans, chemical fumes)
Keeping away from strong fans, air-conditioner jets, smoke, and harsh chemicals reduces trigger factors for eye dryness and redness. The purpose is to prevent extra stimulation of already sensitive surface nerves and vessels. Less exposure to irritants means fewer reflex tears, less rubbing, and a calmer inflammatory environment on the ocular surface.PMC+1 -
Frequent screen breaks and blink exercises
Regular “20-20-20” breaks (every 20 minutes look 20 feet away for 20 seconds) and conscious blinking can help. The goal is to increase complete blinks and tear spreading to prevent dry spots. This works by decreasing the time the eyes stay wide open, improving the distribution of the tear film and reducing exposure-related stress on the cornea.EyeWiki+1 -
Prism glasses for double vision
Prism lenses placed in glasses bend light slightly so the two eyes can see one image instead of two. The purpose is to make reading and walking safer when surgery or strong drugs are not yet used. The mechanism is optical: prisms shift the image to align with the misdirected eye muscles, reducing the brain’s need to “fight” the double signal.PMC+1 -
Temporary eye patching for very disturbing diplopia
Some people get relief by patching one eye part-time, usually for tasks like reading, to stop double vision. The aim is to reduce dizziness, nausea, and risk of falls until more definitive treatment is done. The mechanism is simply blocking one image so the brain only processes one visual stream at a time.PMC+1 -
Eyelid taping at night
Gentle taping of the eyelids closed at bedtime, sometimes with a soft dressing, can protect the cornea if there is lagophthalmos (incomplete lid closure). The purpose is to keep the eye fully covered and moist. Mechanically, taping holds the lids in full contact, limiting air exposure and preventing drying and micro-trauma of the cornea.NCBI+1 -
Protective goggles or moisture chamber glasses
Special sealed or semi-sealed goggles can be worn at night or in windy, dry environments. The goal is to trap humidity around the eye and prevent evaporation. These devices create a small “greenhouse” of moist air, which helps stabilize the tear film and is especially useful in people with severe exposure keratopathy.EyeWiki+1 -
Stress management and psychological support
Graves’ ophthalmopathy can change appearance and cause anxiety or depression. Counseling, support groups, and stress-reduction techniques (breathing, mindfulness, gentle exercise) are important non-drug tools. The purpose is to improve quality of life and treatment adherence. Lower stress may also reduce certain stress-related immune pathways that can make autoimmune disease more active.BMJ Ophthalmology+1 -
Regular follow-up with an eye specialist and endocrinologist
Scheduled visits allow early detection of optic nerve problems, corneal damage, or changes in thyroid levels. The aim is to intervene quickly before permanent harm. Mechanistically, close monitoring lets doctors adjust therapy when disease is still in the “active” phase, when inflammation is reversible and treatments are most effective.PubMed+2Wiley Online Library+2 -
Choice of thyroid treatment to reduce eye risk
In some patients, radioactive iodine for Graves’ disease can temporarily worsen eye problems, especially in smokers. Doctors may choose antithyroid drugs or surgery instead, or combine radioactive iodine with steroid protection. The purpose is to control thyroid disease while avoiding a flare of eye inflammation. This works by limiting sudden immune shifts that activate orbital tissues.Medscape eMedicine+2ScienceDirect+2 -
Orbital radiotherapy (low-dose radiotherapy)
Low-dose radiation to the orbit is a non-drug, non-surgical option often used together with steroids in moderate-severe disease. The aim is to improve eye muscle motility and reduce double vision. Radiation damages overactive lymphocytes and fibrocytes in the orbit, slowly decreasing inflammation and tissue remodeling.BOPSS :+2ResearchGate+2 -
Protecting the cornea with bandage contact lenses (specialist use)
In selected cases, doctors may use soft “bandage” contact lenses to protect the cornea from exposure and friction. The purpose is to give a smooth surface for blinking and healing. These lenses act like a physical shield, spreading forces over a larger area and helping the epithelium recover while lubrication is optimized.EyeWiki+1 -
Rehabilitation planning and cosmetic support
Later in the disease, structured rehabilitation (glasses, cosmetic counseling, staged surgeries) helps patients feel and function better. The aim is to address both visual function and appearance. Mechanistically, careful planning in the inactive phase allows stable tissues to be reshaped or supported in a predictable way, improving eyelid position, eye alignment, and facial symmetry.ScienceDirect+2Nature+2
Drug treatments
Reminder: Many of these are hospital-level drugs with serious side effects. Only specialists should choose or dose them, often using EUGOGO or other expert guidelines.PubMed+1
-
Intravenous methylprednisolone (IVMP – high-dose steroids)
IV methylprednisolone is the standard first-line drug for active, moderate-to-severe Graves’ ophthalmopathy. Guidelines often use weekly infusions over 12 weeks, with a total dose around 4.5 g, adjusted by specialists. The purpose is to rapidly reduce inflammation, redness, and swelling. Steroids work by broadly dampening immune cell activity and cytokine production in the orbit.PubMed+2BOPSS :+2 -
Oral prednisone or prednisolone
Oral steroids may be used after IV pulses or in milder disease when IV therapy is not possible. Doses and tapers vary, for example starting at about 0.5–1 mg/kg/day and slowly reducing under supervision. The goal is to control active inflammation. The mechanism is similar to IV steroids but with slower onset and more systemic side effects like weight gain and mood changes.PMC+1 -
Mycophenolate sodium or mycophenolate mofetil
Mycophenolate, combined with IV methylprednisolone, is now recommended by EUGOGO as a first-line regimen in many patients. It is usually given orally in divided doses, with exact dosing tailored to age, kidney function, and other factors. The purpose is to prolong and deepen the steroid response. It works by blocking lymphocyte proliferation, thereby slowing autoimmune attack in orbital tissues.PubMed+2BOPSS :+2 -
Teprotumumab-trbw (TEPEZZA)
Teprotumumab is the first drug specifically approved by the US FDA for thyroid eye disease. The label recommends an initial 10 mg/kg IV infusion followed by 20 mg/kg every 3 weeks for seven further infusions, in adults. The main goal is to reduce proptosis, inflammation, and diplopia. It works by blocking the IGF-1 receptor on orbital fibroblasts, which reduces autoimmune signaling and tissue expansion.European Medicines Agency (EMA)+4FDA Access Data+4FDA Access Data+4 -
Cyclosporine (systemic)
Cyclosporine is an older immunosuppressant sometimes combined with steroids in difficult cases. It is given orally, with doses and blood levels strictly monitored by specialists. The purpose is to reduce steroid needs and control inflammation. Cyclosporine blocks calcineurin in T cells, decreasing production of IL-2 and other cytokines involved in autoimmune activation in the orbit.BOPSS :+1 -
Rituximab (anti-CD20 monoclonal antibody – off-label)
Rituximab depletes B cells and is used off-label in steroid-resistant or relapsing Graves’ ophthalmopathy. It is given as IV infusions at regimens similar to lymphoma or rheumatoid arthritis protocols. The aim is to reduce autoantibody production and long-term inflammation. Trials have shown mixed but sometimes promising results, so it is usually reserved for selected patients.DNB+3PubMed+3PMC+3 -
Tocilizumab (anti-IL-6 receptor monoclonal antibody – off-label)
Tocilizumab, an IL-6 receptor blocker approved for several autoimmune diseases, has been tested off-label in active, steroid-refractory Graves’ ophthalmopathy. It is given as IV or subcutaneous doses on schedules used for arthritis. The purpose is to dampen IL-6–driven inflammation in orbital tissues, reducing clinical activity scores and sometimes improving eye movement.Frontiers+3BOPSS :+3DNB+3 -
Azathioprine (conventional immunosuppressant)
Azathioprine may be used as a steroid-sparing agent in some centers, often in chronic inflammatory eye disease. It is taken orally, with dosing based on weight and careful blood count monitoring. The aim is to reduce the need for long-term high-dose steroids. Azathioprine interferes with purine synthesis in rapidly dividing immune cells, slowing autoimmune activity.Cureus+1 -
Methotrexate (low-dose immunomodulator)
Low-dose weekly methotrexate, widely used in rheumatology, has been tried in certain thyroid eye disease cases, especially where other options are limited. The purpose is again steroid-sparing and long-term control of low-grade inflammation. Methotrexate reduces proliferation of immune cells and increases anti-inflammatory adenosine signaling, but evidence in Graves’ ophthalmopathy is more limited than for other drugs here.Frontiers+1 -
Conventional antithyroid drugs (methimazole / carbimazole)
These medicines mainly treat Graves’ hyperthyroidism, not the eyes directly, but stable euthyroid state helps the eye disease behave more quietly. They are given orally, with doses adjusted using regular thyroid tests. The mechanism is inhibition of thyroid hormone synthesis, which indirectly reduces thyroid autoantibody activity and immune stress on orbital tissues.Medscape eMedicine+1 -
Levothyroxine (thyroid hormone replacement)
After radioactive iodine or surgery, some patients become hypothyroid and need levothyroxine. Keeping TSH and thyroid hormone levels in a normal range is crucial for eye stability. The drug is taken once daily, fasting, and works by replacing missing T4 hormone so the pituitary and immune system do not stay in a chronically “activated” state.Medscape eMedicine+1 -
Lubricant eye drops and gels (carboxymethylcellulose, hyaluronate)
Although technically “drugs,” these over-the-counter lubricants act locally on the ocular surface. They are used many times per day, with thicker gels at night. Their purpose is symptom control and corneal protection. They work by forming a longer-lasting tear layer, improving tear film stability and reducing micro-injury from blinking and exposure.EyeWiki+1 -
Topical cyclosporine eye drops (e.g., for severe dry eye)
In some patients with intense ocular surface inflammation, cyclosporine eye drops may be prescribed. Doses are usually one drop twice daily over many months. The goal is to improve tear production and reduce surface inflammation. The drug blocks T-cell activation in the conjunctiva and lacrimal gland, supporting a healthier tear film.ScienceDirect+1 -
Topical corticosteroid eye drops (short courses)
Steroid eye drops may be used briefly for surface inflammation, but always under close specialist monitoring because of side effects such as glaucoma and cataracts. The purpose is to calm conjunctival redness and swelling. They work by locally suppressing inflammatory mediators, but must be tapered and monitored with eye pressure checks.EyeWiki+1 -
Botulinum toxin injections (for eyelid retraction / strabismus)
In selected cases, botulinum toxin type A can be injected into specific eyelid or eye muscles. The aim is temporary lowering of the upper lid or weakening of an overacting muscle to reduce exposure or double vision. The toxin blocks acetylcholine release at the neuromuscular junction, producing reversible muscle relaxation for several months.NCBI+1 -
Proton pump inhibitors (supportive when using high-dose steroids)
High-dose systemic steroids can damage the stomach lining. Proton pump inhibitors, like omeprazole, are sometimes added to protect the stomach. They do not treat the eye disease itself but reduce bleeding and ulcer risk. They work by blocking the acid-producing proton pump in stomach cells, lowering gastric acidity while immune therapy continues.PMC+1 -
Calcium and vitamin D (to protect bone during steroid therapy)
Long courses of systemic steroids can weaken bones. Calcium and vitamin D supplements are often recommended as part of the regimen. The purpose is to prevent steroid-induced osteoporosis. Vitamin D improves calcium absorption and bone mineralization, while adequate calcium gives the raw material needed to keep bones strong.Cleveland Clinic Journal of Medicine+1 -
Sirolimus (mTOR inhibitor – experimental)
Sirolimus, an mTOR pathway inhibitor, is being investigated (e.g., SIRGO trial) as a potential therapy for active thyroid eye disease. It is given orally under strict specialist monitoring in research settings. The purpose is to fine-tune T-cell and fibroblast activity. It works by blocking mTOR signaling, a key growth and proliferation pathway in immune and stromal cells.MDPI+1 -
Other biological agents under study (e.g., anti-TNF, small-molecule inhibitors)
Agents such as infliximab or adalimumab (anti-TNF) and novel small-molecule drugs are being explored in small studies and trials. Their purpose is to target specific inflammatory pathways in Graves’ ophthalmopathy. They work by neutralizing cytokines or signaling pathways, but evidence is still limited, so they remain experimental options.Frontiers+1 -
Intravenous immunoglobulin (IVIG – rare use)
IVIG is sometimes used in complex autoimmune eye disease, though less commonly in Graves’ ophthalmopathy. It is given by hospital infusion over several hours. The purpose is immune modulation and temporary reduction of harmful antibodies. It works through several mechanisms, including saturation of Fc receptors and modulation of B-cell activity.Frontiers+1
Dietary molecular supplements
None of these should be started in high doses without medical advice, especially if you have kidney, liver, or bleeding problems.
-
Selenium
Selenium is the best-studied supplement in Graves’ ophthalmopathy. A 6-month course of 100–200 µg/day in mild disease improved eye scores and slowed progression in European studies. It acts as a cofactor for antioxidant enzymes such as glutathione peroxidase, reducing oxidative stress in thyroid and orbital tissues and moderating autoimmune activity.etj.bioscientifica.com+1 -
Vitamin D
Vitamin D deficiency is common in autoimmune disease. Typical doses range from 800–2000 IU/day, but testing and medical guidance are important. The purpose is to support bone health during steroid use and gently modulate immunity. Vitamin D receptors on immune cells can push the system toward a more tolerant, less inflammatory state.Cleveland Clinic Journal of Medicine+1 -
Omega-3 fatty acids (EPA/DHA)
Omega-3 oils from fish or algae (often 1000–2000 mg/day of combined EPA/DHA) support tear film quality and general cardiovascular health. They are thought to shift the balance toward anti-inflammatory lipid mediators. This may ease dry eye symptoms and reduce low-grade inflammation that aggravates ocular surface problems in Graves’ ophthalmopathy.ScienceDirect+1 -
Vitamin C
Vitamin C is a water-soluble antioxidant found in fruits and vegetables. Supplement doses around 200–500 mg/day are commonly used. The purpose is to support collagen and blood vessel health and neutralize free radicals. In chronic inflammation, extra oxidative stress can damage orbital tissues; vitamin C helps buffer some of that stress.PMC+1 -
Vitamin E
Vitamin E is a fat-soluble antioxidant that protects cell membranes, especially in fatty tissues like orbital fat. Modest supplementation (for example, 100–200 IU/day) may support antioxidant defenses, but high doses can increase bleeding risk. It works by interrupting lipid peroxidation chains in cell membranes, reducing oxidative injury around the eyes.PMC+1 -
Zinc
Zinc plays roles in immune regulation and tissue repair. Supplements of 10–25 mg/day are often used short term. The purpose is to support normal immune function and wound healing, especially when chronic illness has affected nutrition. Zinc acts as a cofactor for many enzymes and may help maintain epithelial integrity on the ocular surface.ScienceDirect+1 -
L-carnitine
L-carnitine helps mitochondria burn fatty acids for energy. Some small thyroid studies used doses like 2–4 g/day. In theory, improving mitochondrial function and reducing oxidative stress could indirectly support orbital tissue health, but direct evidence in Graves’ ophthalmopathy is limited, so it should be used cautiously and only under medical advice.ScienceDirect+1 -
Coenzyme Q10 (CoQ10)
CoQ10 is another mitochondrial helper and antioxidant used in doses around 100–200 mg/day. The goal is to improve cellular energy handling and protect membranes from oxidative damage. In chronic autoimmune inflammation, better mitochondrial resilience may help tissues cope with stress, although specific trials in thyroid eye disease are scarce.ScienceDirect+1 -
Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant properties. Standardized extracts might provide 500–1000 mg/day, often with piperine to improve absorption. Its purpose is to gently reduce inflammatory signaling pathways like NF-κB. This could, in theory, lessen systemic inflammation that also affects orbital tissues, but robust clinical data in Graves’ ophthalmopathy are lacking.ScienceDirect+1 -
Probiotic blends
Probiotics aim to support a healthy gut microbiome, which can influence systemic immunity. Doses are usually given as colony-forming units (e.g., billions of CFU per day). The mechanism is indirect: helpful bacteria may reduce gut-driven inflammation and improve metabolic health, potentially making autoimmune diseases a bit easier to manage alongside standard therapies.ScienceDirect+1
Immunity-modulating / regenerative / stem-cell-related therapies
-
Teprotumumab as a targeted “regenerative” therapy
Teprotumumab is not a stem cell drug, but it is a targeted biologic that can reverse some tissue changes, such as reducing proptosis and soft-tissue volume even in chronic disease. By blocking IGF-1 receptor signaling on orbital fibroblasts, it reduces inflammatory and fibrotic activity, which is why some experts consider it part of a regenerative-style approach.PMC+2MDPI+2 -
Rituximab – B-cell–targeted immune re-balancing
Rituximab depletes CD20-positive B cells and can reshape autoantibody production. In some patients, this helps control active Graves’ ophthalmopathy when steroids fail. The idea is to “reset” part of the autoimmune system so orbital tissues are less constantly attacked. Evidence is mixed, so it is used cautiously as a second-line, specialist-only therapy.PubMed+2ScienceDirect+2 -
Tocilizumab – cytokine-focused immunomodulation
By blocking the IL-6 receptor, tocilizumab interferes with a key inflammatory pathway. IL-6 is involved in B-cell maturation and acute-phase responses, and blocking it may reduce orbital inflammation and edema. This focused immunomodulation is closer to “precision medicine,” aiming to correct abnormal immune signals without shutting down the entire immune system.DNB+2Frontiers+2 -
Sirolimus and other mTOR pathway inhibitors (research stage)
mTOR inhibitors like sirolimus are being studied as possible first-line or rescue treatments. They may limit abnormal growth and activation of T cells and fibroblasts in the orbit. In theory, controlling mTOR signaling could reduce tissue expansion and fibrosis, preserving function. These agents are currently being tested in trials, not routine care.MDPI+1 -
Mesenchymal stem cell–based approaches (preclinical / early research)
Experiments using placenta-derived mesenchymal stem cells in animal models and cell cultures show reduced orbital adipogenesis and inflammatory signaling in Graves’ ophthalmopathy. These cells secrete helpful factors that can shift fibroblasts away from fat-storing, pro-inflammatory states toward more normal behavior. At present, this is experimental, not standard treatment for patients.PMC+2SpringerLink+2 -
Exosome-based and other future cell-derived therapies
Reviews now discuss exosomes (tiny vesicles released by stem cells) and other cell-derived products as future options. The idea is to harness the beneficial signals of stem cells without transplanting whole cells. These exosomes may carry anti-inflammatory and tissue-repair molecules that could calm orbital inflammation, but this remains a research topic, not a clinical option yet.PMC+2MDPI+2
Surgical treatments
-
Orbital decompression surgery
Orbital decompression removes parts of the bony walls and/or orbital fat to create more space for swollen tissues. It is done when there is sight-threatening optic nerve compression, severe exposure of the cornea, or disfiguring proptosis. The goal is to reduce pressure on the optic nerve and allow the eye to sit further back, improving both vision and appearance.Frontiers+3NCBI+3EyeWiki+3 -
Strabismus (eye muscle) surgery
Once inflammation is inactive and stable, surgeons may reposition extraocular muscles to correct misalignment and reduce double vision. The purpose is to realign the eyes so they point in the same direction, especially for straight-ahead and reading gaze. This is usually done after decompression, since decompression can change alignment.Nature+2ScienceDirect+2 -
Eyelid retraction surgery
Upper or lower eyelids can be shortened or lengthened by adjusting muscles and adding tissue grafts. The goal is to cover more of the eye, reduce staring appearance, and protect the cornea from exposure. Procedures are tailored to each eyelid and are generally done after the disease is inactive and other surgeries are complete.ScienceDirect+2Nature+2 -
Tarsorrhaphy (temporary or permanent lid-closing procedure)
In very severe exposure keratopathy or when other options are not enough, surgeons may partially sew the eyelids together to protect the cornea. This can be temporary or long-term. The purpose is to shield the cornea and let it heal, trading a smaller opening for much better surface protection.NCBI+1 -
Cosmetic and reconstructive eyelid / orbital surgery
When the disease is inactive, some patients have surgeries to smooth eyelid bags, adjust fat pads, or fine-tune symmetry. The main aim is psychological and functional rehabilitation—helping people feel comfortable in social and work life. These operations respect previous decompression and muscle surgery so that vision remains stable.ScienceDirect+2Nature+2
Prevention tips
-
Do not start or continue smoking; if you already smoke, seek help to quit.ScienceDirect+1
-
Keep thyroid hormone levels in the target range with regular blood tests and follow-up.Medscape eMedicine+1
-
Discuss radioactive iodine risks and protective steroid plans if you have Graves’ disease but no or mild eye disease.ScienceDirect+1
-
Protect your eyes from wind, dust, and bright sunlight with glasses or shields.EyeWiki+1
-
Maintain good general health: sleep, exercise, and a balanced diet that supports immune balance and bone health.BMJ Ophthalmology+1
-
Treat other autoimmune or inflammatory conditions as advised, since overall immune load can influence the eyes.Frontiers+1
-
Keep blood pressure, blood sugar, and cholesterol controlled; vascular health affects the optic nerve’s resilience.Cleveland Clinic Journal of Medicine+1
-
Use artificial tears early when dryness starts; do not wait for pain or damage.EyeWiki+1
-
Attend all eye and endocrine appointments, even when you feel better, so doctors can catch subtle changes.PubMed+1
-
Avoid rubbing your eyes strongly, which can worsen irritation and harm the corneal surface.EyeWiki+1
When to see a doctor urgently
You should see an eye doctor and endocrinologist promptly if you notice new bulging eyes, increasing redness, pain, or persistent double vision. Emergency care is needed if vision becomes blurry, colors look washed out, you lose part of your visual field, or you cannot close your eyes fully, especially with pain or light sensitivity. These can be signs of optic nerve compression or serious corneal damage, which guidelines describe as sight-threatening forms of Graves’ ophthalmopathy that need immediate steroid treatment and sometimes urgent decompression surgery.PubMed+2Wiley Online Library+2
What to eat and what to avoid
-
Eat: Plenty of colorful fruits and vegetables for natural antioxidants (vitamins C, E, carotenoids) to help counter oxidative stress from chronic inflammation.PMC+1
-
Eat: Foods rich in selenium in safe amounts, such as small portions of Brazil nuts (careful not to overdo), fish, eggs, and whole grains, especially if your region has low selenium soil.etj.bioscientifica.com+1
-
Eat: Lean proteins (fish, poultry, legumes) to support tissue repair, including muscles around the eyes, and to maintain strength during any long treatment.Cleveland Clinic Journal of Medicine+1
-
Eat: Healthy fats from nuts, seeds, and oily fish, which provide omega-3 fatty acids that support tear film and may gently reduce inflammation.ScienceDirect+1
-
Eat: Calcium- and vitamin D-rich foods (dairy, fortified plant milks, small fish with bones) when using steroids or if you are at risk for bone loss.Cleveland Clinic Journal of Medicine+1
-
Avoid: Excessive iodine intake from very large amounts of kelp or iodine supplements unless prescribed, because abrupt iodine changes can disturb thyroid control.Medscape eMedicine+1
-
Avoid: Very salty processed foods that can increase fluid retention and make swelling around the eyes and elsewhere worse.Cleveland Clinic Journal of Medicine+1
-
Avoid: Excess caffeine and energy drinks late in the day, especially if you are already anxious or have a fast heart rate from thyroid issues.Medscape eMedicine+1
-
Avoid: Alcohol excess, which interferes with sleep, immune balance, and can interact with many medicines used in Graves’ ophthalmopathy.Cleveland Clinic Journal of Medicine+1
-
Avoid: Unverified “thyroid” or “immune booster” supplements bought without medical advice; these can contain hidden hormones or high iodine and may worsen disease.Cleveland Clinic Journal of Medicine+1
Frequently asked questions
-
Is Graves’ ophthalmopathy the same as Graves’ disease?
They are closely linked but not identical. Graves’ disease mainly affects the thyroid gland, while Graves’ ophthalmopathy affects tissues around the eyes. Many people have both, but some develop eye disease after or even without obvious thyroid problems.PMC+1 -
Can Graves’ ophthalmopathy go away on its own?
The inflammation often has an “active” phase lasting months to a couple of years, then settles into an “inactive” phase. Mild disease can improve significantly, especially if you stop smoking and thyroid levels are controlled, but some changes, like scarred muscles, may remain without surgery.PubMed+1 -
Does better thyroid control always fix the eyes?
Good thyroid control helps, but it does not guarantee that eye problems will disappear. The autoimmune attack on orbital tissues can follow its own course, which is why eye-specific treatments, from lubricants to teprotumumab or surgery, are often needed in addition to thyroid therapy.Medscape eMedicine+2etj.bioscientifica.com+2 -
Is teprotumumab a cure?
Teprotumumab can significantly improve proptosis and inflammation and may feel like a “game-changer” for many patients, but it is not a complete cure. Some patients relapse, some do not respond, and side effects must be monitored carefully. It is one strong option among many in modern treatment plans.Cleveland Clinic Journal of Medicine+3FDA Access Data+3PMC+3 -
Can children or teenagers get Graves’ ophthalmopathy?
Yes, but it is less common than in adults. Because growth, schooling, and mental health are so important, young people with signs of eye disease should see experienced pediatric endocrinology and ophthalmology teams quickly so that treatments are tailored safely to their age.EyeWiki+1 -
Will I always look “staring” or “surprised”?
Not necessarily. As inflammation settles and treatments take effect, eyelid position and swelling can improve. Later, reconstructive surgeries may further normalize appearance. Many people end up with a look that feels acceptable or close to their former appearance.ScienceDirect+2Nature+2 -
Is surgery always needed?
No. Many patients with mild disease never need surgery and do well with non-drug measures and medical treatment. Surgery is mainly for sight-threatening problems or long-term changes (proptosis, double vision, lid retraction) that remain after the disease becomes inactive.NCBI+2Nature+2 -
Can I wear contact lenses?
Some people can still wear contact lenses, but dry eye and exposure can make them uncomfortable or unsafe. An eye specialist should evaluate whether lenses or special bandage lenses are suitable, and how often they can be worn without harming the cornea.EyeWiki+1 -
Is Graves’ ophthalmopathy painful?
Pain varies. Some people have only discomfort and grittiness, while others have deep ache behind the eye, especially when looking up or sideways. Severe or new pain, especially with vision change, is a warning sign and should be checked urgently.PMC+2PubMed+2 -
Can pregnancy make Graves’ ophthalmopathy worse?
Pregnancy changes the immune system and thyroid needs. Eye disease activity usually follows overall autoimmune activity, which can fluctuate around pregnancy and after birth. Planning pregnancy with your care team, and close follow-up, helps reduce risks for both mother and baby.Wiley Online Library+1 -
Is there a special “thyroid eye” diet?
There is no single magic diet, but a pattern rich in fruits, vegetables, lean proteins, healthy fats, and adequate selenium, calcium, and vitamin D while avoiding smoking, heavy alcohol, and highly processed foods supports overall treatment and bone health.etj.bioscientifica.com+2Cleveland Clinic Journal of Medicine+2 -
Can I use the computer or phone normally?
Yes, but long screen time can worsen dryness and strain. Using artificial tears, taking frequent breaks, and adjusting screen brightness and height can make digital use more comfortable and safer for your eyes.EyeWiki+1 -
Are these new biologic and stem-cell therapies safe?
Teprotumumab and other biologics have shown strong benefits but also have specific side effects that need careful monitoring. Stem-cell-based approaches are still in preclinical or early research. Long-term safety and best use patterns are still being studied, so they should only be used in trials or under strict specialist programs.MDPI+3PMC+3Frontiers+3 -
Can Graves’ ophthalmopathy come back after treatment?
Yes, relapses can happen, especially if smoking continues or thyroid levels become unstable again. Ongoing follow-up, healthy habits, and early attention to new symptoms help catch recurrences before they become severe.PubMed+2Wiley Online Library+2 -
What is the most important thing I can do myself?
From a self-care point of view, not smoking, keeping thyroid levels well-controlled, protecting and lubricating your eyes, and attending all specialist appointments are the most powerful actions. These steps work together with medical treatments to reduce the chance of long-term vision problems.PubMed+3ScienceDirect+3Medscape eMedicine+3
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December o3 , 2025.

